BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27905535)

  • 1. Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine.
    Raeven RH; Brummelman J; Pennings JL; van der Maas L; Tilstra W; Helm K; van Riet E; Jiskoot W; van Els CA; Han WG; Kersten GF; Metz B
    Sci Rep; 2016 Dec; 6():38240. PubMed ID: 27905535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity.
    Raeven RH; van der Maas L; Tilstra W; Uittenbogaard JP; Bindels TH; Kuipers B; van der Ark A; Pennings JL; van Riet E; Jiskoot W; Kersten GF; Metz B
    J Proteome Res; 2015 Jul; 14(7):2929-42. PubMed ID: 25988566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
    Raeven RHM; Rockx-Brouwer D; Kanojia G; van der Maas L; Bindels THE; Ten Have R; van Riet E; Metz B; Kersten GFA
    Sci Rep; 2020 Apr; 10(1):7396. PubMed ID: 32355188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization.
    Kanojia G; Raeven RHM; van der Maas L; Bindels THE; van Riet E; Metz B; Soema PC; Ten Have R; Frijlink HW; Amorij JP; Kersten GFA
    J Control Release; 2018 Sep; 286():167-178. PubMed ID: 30048656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane Vesicles Derived from Bordetella bronchiseptica: Active Constituent of a New Vaccine against Infections Caused by This Pathogen.
    Bottero D; Zurita ME; Gaillard ME; Bartel E; Vercellini C; Hozbor D
    Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29180369
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model.
    Misiak A; Leuzzi R; Allen AC; Galletti B; Baudner BC; D'Oro U; O'Hagan DT; Pizza M; Seubert A; Mills KHG
    Vaccine; 2017 Sep; 35(39):5256-5263. PubMed ID: 28823618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative diphtheria, tetanus and whooping cough immunization schedule to evoke a Th2 tetanus and a Th1 pertussis immune response.
    Lavigne MV; Castro M; Andino J; Manghi M
    Microbes Infect; 2004 Apr; 6(5):481-4. PubMed ID: 15109963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs.
    Jennings-Gee J; Quataert S; Ganguly T; D'Agostino R; Deora R; Dubey P
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29531137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein from Bordetella pertussis in mice models.
    Yılmaz Ç; Apak A; Özcengiz E; Özcengiz G
    Microbiol Immunol; 2016 Nov; 60(11):717-724. PubMed ID: 27761933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acellular pertussis vaccine based on outer membrane vesicles capable of conferring both long-lasting immunity and protection against different strain genotypes.
    Gaillard ME; Bottero D; Errea A; Ormazábal M; Zurita ME; Moreno G; Rumbo M; Castuma C; Bartel E; Flores D; van der Ley P; van der Ark A; F Hozbor D
    Vaccine; 2014 Feb; 32(8):931-7. PubMed ID: 24397896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outer membrane vesicles derived from
    Pschunder B; Locati L; López O; Martin Aispuro P; Zurita E; Stuible M; Durocher Y; Hozbor D
    Front Immunol; 2024; 15():1387534. PubMed ID: 38650936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the immune response induced by pertussis OMVs-based vaccine.
    Bottero D; Gaillard ME; Zurita E; Moreno G; Martinez DS; Bartel E; Bravo S; Carriquiriborde F; Errea A; Castuma C; Rumbo M; Hozbor D
    Vaccine; 2016 Jun; 34(28):3303-9. PubMed ID: 27151884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis of Pulmonary Transcriptomes from Differently Primed Mice Identifies Molecular Signatures to Differentiate Immune Responses following
    Raeven RH; Pennings JL; van Riet E; Kersten GF; Metz B
    J Immunol Res; 2017; 2017():8512847. PubMed ID: 28243609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Virulence Proteins in Protection Conferred by
    Raeven RHM; van Vlies N; Salverda MLM; van der Maas L; Uittenbogaard JP; Bindels THE; Rigters J; Verhagen LM; Kruijer S; van Riet E; Metz B; van der Ark AAJ
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32751680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer-Membrane-Vesicle-Associated O Antigen, a Crucial Component for Protecting Against
    Bottero D; Zurita ME; Gaillard ME; Carriquiriborde F; Martin Aispuro P; Elizagaray M; Bartel E; Castuma C; Hozbor D
    Front Immunol; 2018; 9():2501. PubMed ID: 30459769
    [No Abstract]   [Full Text] [Related]  

  • 19. Adaptive immune response to whole cell pertussis vaccine reflects vaccine quality: A possible complementation to the Pertussis Serological Potency test.
    Hoonakker ME; Verhagen LM; van der Maas L; Metz B; Uittenbogaard JP; van de Waterbeemd B; van Els CA; van Eden W; Hendriksen CF; Sloots A; Han WG
    Vaccine; 2016 Aug; 34(37):4429-36. PubMed ID: 27452867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.
    Shahin RD; Brennan MJ; Li ZM; Meade BD; Manclark CR
    J Exp Med; 1990 Jan; 171(1):63-73. PubMed ID: 2295882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.